文献速递临床试验与 GCP基础与转化研究

中药改善癌症生存者癌因性疲劳的生活质量干预研究方案:HERBAL试验

A study protocol for HEalth-Related quality of life-intervention in survivors of Breast and other cancers experiencing cancer-related fatigue using TraditionAL Chinese Medicine: the HERBAL trial.
PubMed 文献 · Trials · 2020-11-04

主要结局为第8周随访时的整体健康与生活质量状态,次要结局包括疲劳水平、癌症相关认知障碍及生活质量,并评估不良事件发生率及与癌因性疲劳相关血液生物标志物的影响。

要点

  • 改良香贝养荣汤每日服用8周,随机双盲安慰剂对照评估癌因性疲劳。
  • 主要结局为第8周整体健康与生活质量,次要含疲劳、认知及生物标志物。

核心结论

  • 该试验旨在评估改良香贝养荣汤改善癌症生存者癌因性疲劳和生活质量的有效性与安全性。

研究设计与样本

  • 参与者每日服用研究煎剂共8周,在基线及第4、8、10周进行评估。

关键数值与推荐

  • 主要结局为第8周随访时的整体健康与生活质量状态。
  • 次要结局包括患者报告结局评估的疲劳水平、癌症相关认知障碍和生活质量,以及不良事件发生率和与癌因性疲劳相关的血液生物标志物影响。

临床怎么用

  • 该方案结果将为未来大规模随机对照试验提供临床数据,并帮助阐明癌因性疲劳的生物学机制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cancer-related fatigue (CRF) is a debilitating condition which commonly affects cancer survivors. The management of CRF remains a challenge due to the lack of effective pharmacological interventions. Traditional Chinese medicine (TCM) could be a potential therapeutic option for CRF. The modified Xiang Bei Yang Rong Tang (XBYRT) is a TCM herbal decoction, formulated to improve fatigue symptoms in cancer survivors. This clinical trial aims to evaluate the efficacy and safety of XBYRT in improving CRF and quality of life (QOL) of cancer survivors. METHODS: This is a single centre, randomized, double-blind, placebo-controlled, parallel trial. Eighty cancer survivors will be recruited and randomized to receive the XBYRT or placebo decoction, in a ratio of 1:1. Participants will consume the XBYRT/placebo decoction daily for 8 weeks and undergo assessments at baseline and 4, 8 and 10 weeks after baseline. The participants will be assessed for patient-reported outcomes (PRO), blood biomarkers and adverse events at each time point. The primary outcome is the overall health and QOL status, at 8 weeks follow-up. The secondary outcomes are the effects of XBYRT on fatigue levels, cancer-related cognitive impairment and QOL, as assessed by PRO. The incidence of adverse events and the effects of the XBYRT decoction on blood biomarkers associated with CRF will also be evaluated. DISCUSSION: Efficacy and safety outcomes from this trial will provide important clinical data to guide future large-scale randomized controlled trials, and the evaluation of the objective blood biomarkers can help to delineate the biological mechanisms of CRF. TRIAL REGISTRATION NUMBER: ClinicalTrials.gov NCT04104113 . Registered on 26 September 2019.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Yap NY, Loo WS, Zheng HF, et al. A study protocol for HEalth-Related quality of life-intervention in survivors of Breast and other cancers experiencing cancer-related fatigue using TraditionAL Chinese Medicine: the HERBAL trial. Trials. 2020. PMID: 33187543. doi:10.1186/s13063-020-04810-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。